Leo Puri Appointed as Chairman of Fortis Healthcare
Fortis Healthcare Limited, a prominent healthcare provider in India, recently announced the appointment of Leo Puri as its new Chairman of the Board, effective December 27, 2024. Puri, a seasoned leader with extensive experience in the financial sector, will serve as an Additional Independent Director for a five-year term, pending shareholder approval.
Puri succeeds Indrajit Banerjee, who has been serving as the interim Chairman since October 1, 2024. Banerjee will continue as a member of the board and retain his committee positions within the company.
With over four decades of experience, Puri brings a wealth of knowledge to Fortis Healthcare. His most recent role was as the executive Chairman for South & South East Asia at JP Morgan Chase until late 2023. Currently, he holds the position of senior advisor and Chairman, India at Apax, a global private equity firm. Puri’s impressive career also includes senior positions at McKinsey & Company and UTI Asset Management Company.
In addition to his new role at Fortis Healthcare, Puri serves as an independent director on the boards of several major corporations, including Tata Sons, Hindustan Unilever, and Dr Reddy’s Laboratories.
Fortis Healthcare operates 28 healthcare facilities across India, offering approximately 4,700 operational beds and 419 diagnostics labs. The company’s focus is on providing integrated healthcare services through hospitals, diagnostics, and daycare specialty facilities.
As of noon today, the shares of Fortis Healthcare Limited were trading at ₹659.95, down ₹12.25 or 1.82 per cent on the NSE.
Overall, Leo Puri’s appointment as Chairman of Fortis Healthcare signals a new chapter for the company, with his vast experience and expertise expected to further strengthen its position in the healthcare industry.
